No differences between Calendula cream and aqueous cream in the prevention of acute radiation skin reactions - Results from a randomised blinded trial

European Journal of Oncology Nursing

Volumn 17, Issue 4, 2013, Pages 429-435

  Sharp, Lena ^a,b   Finnilä, Kristina ^a,c   Johansson, Hemming ^a   Abrahamsson, Marie ^a   Hatschek, Thomas ^a,b   Bergenmar, Mia ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Aqueous cream; Breast cancer; Calendula; Dermatitis; Patient reported outcomes; Radiation skin reaction; Radiotherapy; Randomised trial; Skin

Indexed keywords

PLANT EXTRACT; SKIN CREAM;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST TUMOR; CALENDULA; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; MEDICATION COMPLIANCE; MIDDLE AGED; PHYTOTHERAPY; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DERMATITIS; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CALENDULA; FEMALE; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; QUALITY OF LIFE; QUESTIONNAIRES; RADIODERMATITIS; RADIOTHERAPY, ADJUVANT; REGRESSION ANALYSIS; SINGLE-BLIND METHOD; SKIN CREAM; TREATMENT OUTCOME;

EID: 84879262838     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2012.11.003     Document Type: Article

References (26)

1. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of The National Cancer Institute 1993, 85:365-376.
2. Bijur P.E., Silver W., Gallagher E.J. Reliability of the visual analog scale for measurement of acute pain. Academic Emergency Medicine 2001, 8:1153-1157.
3. Bottomley A., Jones D., Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European Journal of Cancer 2009, 45:347-353.
4. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Research and treatment of cancer (EORTC). International Journal of Radiation Oncology Biology Physics 1995, 31:1341-1346.
5. Cull A.M. Cancer-specific quality of life questionnaires: the state of the art in Europe. European Journal of Cancer 1997, 33(Suppl. 6):S3-S7.
6. Fayers P.M., Aaronson N.K., Bjordal K., Groenvold M., Curran D., Bottomley A., et al. EORTC QLQ-C30 Scoring Manual 2001, On behalf of the EORTC Quality of Life Group, EORTC, Brussels. third ed.
7. Feight D., Baney T., Bruce S., McQuestion M. Putting evidence into practice. Clinical Journal of Oncology Nursing 2011, 15:481-492.
8. Fisher J., Scott C., Stevens R., Marconi B., Champion L., Freedman G.M., et al. Randomized phase III study comparing Best Supportive Care to Biafine as a prophylactic agent for radiation-induced skin toxicity for women undergoing breast irradiation: Radiation Therapy Oncology Group (RTOG) 97-13. International Journal of Radiation Oncology Biology Physics 2000, 48:1307-1310.
9. Hays R.D., Martin S.A., Sesti A.M., Spritzer K.L. Psychometric properties of the Medical outcomes study sleep measure. Sleep Med. 2005, 6:41-44.
10. Heggie S., Bryant G.P., Tripcony L., Keller J., Rose P., Glendenning M., et al. APhase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nursing 2002, 25:442-451.
11. Kumar S., Juresic E., Barton M., Shafiq J. Management of skin toxicity during radiation therapy: a review of the evidence. Journal of Medical Imaging and Radiation Oncology 2010, 54:264-279.
12. Lipscomb J., Reeve B.B., Clauser S.B., Abrams J.S., Bruner D.W., Burke L.B., et al. Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. Journal of Clinical Oncology 2007, 25:5133-5140.
13. Lopez E., Nunez M.I., Guerrero M.R., del Moral R., de Dios Luna J., del Mar Rodriguez M., et al. Breast cancer acute radiotherapy morbidity evaluated by different scoring systems. Breast Cancer Research and Treatment 2002, 73:127-134.
14. Michelson H., Bolund C., Nilsson B., Brandberg Y. Health-related quality of life measured by the EORTC QLQ-C30-reference values from a large sample of Swedish population. Acta Oncologica 2000, 39:477-484.
15. Miller R.C., Schwartz D.J., Sloan J.A., Griffin P.C., Deming R.L., Anders J.C., et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. International Journal of Radiation Oncology Biology Physics 2011, 79:1460-1466.
16. Neben-Wittich M.A., Atherton P.J., Schwartz D.J., Sloan J.A., Griffin P.C., Deming R.L., et al. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). International Journal of Radiation Oncology Biology Physics 2011, 81:397-402.
17. Pardo Masferrer J., Murcia Mejia M., Vidal Fernandez M., Alvarado Astudillo A., Hernandez Armenteros M.L., Macias Hernandez V., et al. Prophylaxis with a cream containing urea reduces the incidence and severity of radio-induced dermatitis. Clinical and Translational Oncology 2010, 12:43-48.
18. Pinnix C., Perkins G.H., Strom E.A., Tereffe W., Woodward W., Oh J.L., et al. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. International Journal of Radiation Oncology Biology Physics 2012, 83:1089-1094.
19. Pommier P., Gomez F., Sunyach M.P., D'Hombres A., Carrie C., Montbarbon X., et al. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. Journal of Clinical Oncology 2004, 22:1447-1453.
20. Porock D., Kristjanson L., Nikoletti S., Cameron F., Pedler P. Predicting the severity of radiation skin reactions in women with breast cancer. Oncology Nursing Forum 1998, 25:1019-1029.
21. Richardson J., Smith J.E., McIntyre M., Thomas R., Pilkington K. Aloe vera for preventing radiation-induced skin reactions: a systematic literature review. Clinical Oncology (R Coll. Radiol) 2005, 17:478-484.
22. Sharp L., Johansson H., Landin Y., Moegelin I.M., Bergenmar M. Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - a pilot study. European Journal of Cancer 2011, 47:2665-2672.
23. Spritzer K.L., Hays R.D. MOS Sleep Scale: a Manual for Use and Scoring, Version 1.0 2003, RAND, Los Angeles, CA.
24. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. American Journal of Epidemiology 1986, 123:174-184.
25. Watkins Bruner D., Movsas B., Basch E. Capturing the patient perspective: patient-reported outcomes as clinical trial endpoints. Contemporary Clinical Trials 2012 2012, 33(1):23-28.
26. Wells M., Macmillan M., Raab G., MacBride S., Bell N., MacKinnon K., et al. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiotherapy and Oncology 2004, 73:153-162.